Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 04:43 | 2026-03-02 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; See Remarks | Pharmaceutical Preparations | SALE | $25.18 | 3,687 | $92,846 | 175,178 | -2.1% |
| 2026-02-05 03:21 | 2026-02-02 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; See Remarks | Pharmaceutical Preparations | SALE | $25.50 | 2,052 | $52,323 | 148,865 | -1.4% |
| 2025-11-11 01:42 | 2025-11-06 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; See Remarks | Pharmaceutical Preparations | SALE | $25.16 | 29,131 | $732,927 | 150,193 | -16.2% |
| 2025-10-06 22:15 | 2025-10-02 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; See Remarks | Pharmaceutical Preparations | SALE | $20.04 | 4,504 | $90,263 | 179,324 | -2.5% |
| 2025-05-20 23:37 | 2025-05-19 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; See Remarks | Pharmaceutical Preparations | SALE | $14.07 | 7,451 | $104,850 | 183,104 | -3.9% |
| 2025-02-05 04:00 | 2025-02-03 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; See Remarks | Pharmaceutical Preparations | SALE | $12.70 | 2,173 | $27,597 | 135,555 | -1.6% |
| 2024-12-04 00:17 | 2024-11-30 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; See Remarks | Pharmaceutical Preparations | BUY | $7.11 | 1,093 | $7,767 | 137,728 | +0.8% |
| 2024-10-03 23:55 | 2024-10-02 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; SVP Chief Commercial Officer | Pharmaceutical Preparations | SALE | $10.01 | 3,725 | $37,295 | 136,635 | -2.7% |
| 2024-05-21 00:12 | 2024-05-17 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; SVP Chief Commercial Officer | Pharmaceutical Preparations | SALE | $8.98 | 7,640 | $68,582 | 140,360 | -5.2% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.